Richard (Rick) Mills
Ahead of the Herd
As a general rule, the most successful man in life is the man who has the best information
Sernova is now a clinical stage company involved in human clinical trials which require much more scrutiny and regulatory control by the University and Health Canada and of course a lot more documentation by the company.
Unfortunately there are some investors who are selling off the stock thinking that nothing is happening within the company – nothing could be further from the truth.
As has been true for the past three years Sernova is advancing as quickly as ever. Provided below is a brief update of where things stand:
- SVA has been approved by Health Canada to start clinical trials at the University of Alberta
- All the contract manufacturing has been completed, sterilization validation completed and product shipped to the clinical site
- All the final paperwork has been received by the University and approvals provided to proceed
- Sernova has conducted their Investigator's Meeting with Dr. Shapiro's team to review all the documents, clinical study processes, surgical procedures, case report forms, etc.
- Dr. Shapiro has completed surgical practice of both implanting the Cell Pouch(TM) and transplanting islets so he is well prepared to begin the surgical procedures
- SVA has hired an independent clinical monitor to monitor the study
- There is good patient interest. Dr. Shapiro's team has been screening patients to ensure patients who enter the study meet the inclusion criteria and are suitable for the trial
- Sernova is getting very close to implanting patients with the Cell Pouch(TM) having ensured that everything is appropriately in place
The clinical trial process takes some time as there are many, many considerations to get things right the first time. Investors need to understand that Sernova is progressing as it should be, and is moving in a very exciting direction. This trial is a first “in world trial” of such an important device for cell transplantation and it is happening in Canada with the support of Canadian investors.
Recent Sernova Corp TSX.V – SVA articles by Richard (Rick) Mills:
https://aheadoftheherd.com/Newsletter/2012/Ahead-Of-The-Herd-With-Sernova.html
https://aheadoftheherd.com/Newsletter/2011/The-Rule-of-Halves.html
Sernova should be on every investors radar screen. Is this company, and its upcoming human trials, on yours?
If not, maybe it should be.
Richard (Rick) Mills
rick@aheadoftheherd.com
www.aheadoftheherd.com